Maryam GHOLAMALIZADEHUnit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.

ePoster Stage 1: Cancer

Sep 7, 2026 — 02:00 pm - 3:30 PMHall Europa - Stage 1

REGENERATION INTERIM ANALYSIS: THE EFFECTIVENESS OF NUTRITION THERAPY FOR PATIENTS WITH GASTROINTESTINAL TUMORS DURING REHABILITATION

IS TUBE FEEDING FEASIBLE IN PATIENTS UNDERGOING A STEM CELL TRANSPLANTATION?

INFLAMMATORY-CATABOLIC MECHANISMS UNDERLYING ANOREXIA IN MYELOFIBROSIS: EVIDENCE BEYOND SPLENOMEGALY

GUT-DERIVED INDOLE-3-LACTIC ACID EXACERBATES ADIPOSE TISSUE LOSS IN CANCER CACHEXIA BY SUPPRESSING ADIPOGENIC SIGNALING

OTOPETRIN 1 PROTECTS AGAINST ADIPOSE TISSUE WASTING DURING CANCER CACHEXIA PROGRESSION

DEFINING INFLAMMATION IN GLIM-BASED CANCER CACHEXIA: NON-LINEAR PROGNOSTIC ROLE OF CRP AND COMPARISON OF CANDIDATE CUTOFFS

FROM PRECLINICAL TO CLINICAL OBESITY: PROGRESSIVE DECLINE IN CELLULAR INTEGRITY AND FAT-FREE MASS IN BREAST CANCER

COMPARISON OF PERMANENT AND TEMPORARY CENTRAL VENOUS CATHETERS IN PATIENTS RECEIVING PARENTERAL NUTRITION: A SAFETY ANALYSIS OF CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTIONS

PROGNOSTIC IMPACT OF BODY COMPOSITION AND SARCOPENIA PARAMETERS ON SURVIVAL IN CERVICAL CANCER PATIENTS TREATED WITH CURATIVE CHEMORADIOTHERAPY

EVALUATING EVIDENCE ON POLYPHENOL INTAKE AND DIGESTIVE SYSTEM CANCER RISK: AN UMBRELLA REVIEW OF META-ANALYSES AND SYSTEMATIC REVIEWS

Sep 7, 2026 — 02:00 pm - 3:30 PM
Hall Europa - Stage 1